Citigroup Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price objective reduced by research analysts at Citigroup from $1,450.00 to $1,400.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the medical instruments supplier’s stock. Citigroup’s target price indicates a potential upside of 12.30% from the stock’s current price.

Several other brokerages have also recently commented on MTD. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating on the stock. Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Robert W. Baird upped their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,380.50.

Mettler-Toledo International Stock Down 1.7 %

MTD traded down $21.94 during trading on Tuesday, hitting $1,246.71. The company had a trading volume of 53,118 shares, compared to its average volume of 136,814. The company has a market capitalization of $26.08 billion, a PE ratio of 30.74, a PEG ratio of 3.30 and a beta of 1.13. Mettler-Toledo International has a one year low of $1,142.91 and a one year high of $1,546.93. The firm’s 50-day moving average price is $1,291.90 and its 200 day moving average price is $1,327.92.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Sell-side analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 790 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently bought and sold shares of the company. Robeco Institutional Asset Management B.V. boosted its position in shares of Mettler-Toledo International by 46.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 29,136 shares of the medical instruments supplier’s stock worth $43,695,000 after acquiring an additional 9,306 shares in the last quarter. National Pension Service lifted its position in shares of Mettler-Toledo International by 8.0% during the 3rd quarter. National Pension Service now owns 34,039 shares of the medical instruments supplier’s stock worth $51,048,000 after buying an additional 2,521 shares during the last quarter. Asset Management One Co. Ltd. boosted its stake in Mettler-Toledo International by 4.6% in the third quarter. Asset Management One Co. Ltd. now owns 18,545 shares of the medical instruments supplier’s stock valued at $27,812,000 after buying an additional 813 shares in the last quarter. QRG Capital Management Inc. grew its position in Mettler-Toledo International by 9.1% in the third quarter. QRG Capital Management Inc. now owns 382 shares of the medical instruments supplier’s stock valued at $573,000 after acquiring an additional 32 shares during the last quarter. Finally, PDS Planning Inc bought a new position in shares of Mettler-Toledo International in the third quarter worth about $211,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.